Zydus gets USFDA approval for injectable vitamin C

Zydus gets USFDA approval for injectable vitamin C — Zydus Lifesciences has received approval from the USFDA for its Abbreviated New Drug Application (ANDA) for ascorbic acid (vitamin C) injection, 1g/5mL. The product is a generic version of Fresenius Kabi’s VITAL-5. This approval expands Zydus’s portfolio in the US market, reinforcing its injectables segment.

📊 STOCKS: $ZYDUSLIFE | 🏢 SECTOR: Pharma | #MEDIUMIMPACT #USFDA